Identification of IspD as a novel target for tuberculosis treatment using compound M6

• Lijun Dong,
• Lijun Dong,
• Hui Qi,
• Yue Zhu,
• Yuma Yang,
• Yue Zhao,
• Sihan Zhang,
• Yongqiang Su,
• Taiyun Yue,
• Xiancai Du,
• Hetian Lei,
• Yanhui Yang

Affiliations

Lijun Dong

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Lijun Dong

Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China

Hui Qi

Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China

Yue Zhu

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Yuma Yang

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Yue Zhao

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Sihan Zhang

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Yongqiang Su

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Taiyun Yue

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China

Xiancai Du

School of Medicine, Southern University of Science and Technology, Shenzhen, China

Hetian Lei

Department of Ophthalmology, The First People’s Hospital of Chenzhou, Chenzhou, China

Yanhui Yang

Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, The School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China